Brilliant Violet 711a,,cents anti-T-bet [4B10]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0475013
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $363.00
About this award
BioLegend Inc. was awarded contract A207_PO-0475013 by the University of Virginia on August 29, 2026, for the procurement of laboratory reagents. The contract encompasses the delivery of Brilliant Violet 711a, a fluorescent antibody conjugate targeting T-bet (anti-T-bet [4B10]), a protein marker used in flow cytometry and immunological research applications. The line item specifies a quantity of two units at a unit price of $181.50 each, with delivery directed to Selin Ustel.
The total cumulative contract value is $363.00. This procurement represents a standard materials purchase by the University of Virginia, a state institution in Virginia, for research or laboratory purposes. BioLegend Inc. serves as the prime contractor responsible for fulfilling the delivery obligation under this purchase order.
Line items
| Item | Total |
|---|---|
| Brilliant Violet 711a,,cents anti-T-bet [4B10] | $363.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0475013?
Contract A207_PO-0475013 was awarded to BIOLEGEND INC. by University of Virginia on August 29, 2026.
How much is contract A207_PO-0475013 worth?
Its cumulative value is $363.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award